CIK: 0001792126 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $545,070 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | 1,750,000 | $68,758 | 12.6% | $28.97 | +39.0% | COM NEW | 23282W605 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,500,000 | $67,830 | 12.4% | $51.29 | -11.1% | COM | 03753U106 |
| IDYA | IDEAYA BIOSCIENCES INC | 3,750,000 | $51,750 | 9.5% | $17.43 | -36.2% | COM | 45166A102 |
| DSGN | DESIGN THERAPEUTICS INC | 2,797,501 | $39,165 | 7.2% | $30.93 | -56.3% | COM | 25056L103 |
| SRPT | SAREPTA THERAPEUTICS INC | 400,000 | $29,984 | 5.5% | $73.57 | 0.0% | COM | 803607100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 300,000 | $29,244 | 5.4% | $84.75 | +8.9% | COM | 64125C109 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,700,000 | $28,526 | 5.2% | $27.84 | — | SPONSORED ADS | 088786108 |
| VTYX | VENTYX BIOSCIENCES INC | 2,312,680 | $28,284 | 5.2% | $17.42 | -14.2% | COM | 92332V107 |
| — | HORIZON THERAPEUTICS PUB L | 350,000 | $27,916 | 5.1% | $79.76 | — | SHS | G46188101 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,136,352 | $25,373 | 4.7% | $37.43 | -70.9% | COM | 00166B105 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,000,000 | $21,310 | 3.9% | $17.41 | +17.8% | COM | 03969K108 |
| DYN | DYNE THERAPEUTICS INC | 2,900,000 | $19,923 | 3.7% | $18.68 | -63.1% | COM | 26818M108 |
| — | KARUNA THERAPEUTICS INC | 150,000 | $18,977 | 3.5% | $115.76 | — | COM | 48576A100 |
| — | DICE THERAPEUTICS INC | 985,251 | $15,291 | 2.8% | $30.50 | — | COM | 23345J104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,743,875 | $15,238 | 2.8% | $46.89 | -93.2% | COM | 68062P106 |
| — | CHEMOCENTRYX INC | 600,000 | $14,868 | 2.7% | $24.78 | — | COM | 16383L106 |
| FULC | FULCRUM THERAPEUTICS INC | 1,950,000 | $9,555 | 1.8% | $14.01 | -30.2% | COM | 359616109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 650,000 | $9,159 | 1.7% | $18.68 | 0.0% | COM | 004225108 |
| — | KEZAR LIFE SCIENCES INC | 950,000 | $7,857 | 1.4% | $7.93 | — | COM | 49372L100 |
| IPSC | CENTURY THERAPEUTICS INC | 476,559 | $4,003 | 0.7% | $25.37 | -61.3% | COM | 15673T100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 399,801 | $1,947 | 0.4% | $21.54 | — | SPONSORED ADS | 152309100 |
| — | SPRUCE BIOSCIENCES INC | 1,000,000 | $1,740 | 0.3% | $4.46 | — | COM | 85209E109 |
| — | INSTIL BIO INC | 369,800 | $1,708 | 0.3% | $10.75 | — | COM | 45783C101 |
| — | TALARIS THERAPEUTICS INC | 270,987 | $1,222 | 0.2% | $14.69 | — | COM | 87410C104 |
| EWTX | EDGEWISE THERAPEUTICS INC | 150,000 | $1,194 | 0.2% | $28.99 | -73.9% | COM | 28036F105 |
| TYRA | TYRA BIOSCIENCES INC | 166,526 | $1,191 | 0.2% | $19.11 | -58.3% | COM | 90240B106 |
| LIANY | LIANBIO | 394,486 | $852 | 0.2% | $6.16 | — | SPONSORED ADS | 53000N108 |
| — | ATHIRA PHARMA INC | 220,000 | $671 | 0.1% | $14.51 | — | COM | 04746L104 |
| — | VIGIL NEUROSCIENCE INC | 205,595 | $530 | 0.1% | $7.03 | — | COM | 92673K108 |
| PYXS | PYXIS ONCOLOGY INC | 220,434 | $525 | 0.1% | $11.45 | -76.7% | COMMON STOCK | 747324101 |
| NUVL | NUVALENT INC | 33,887 | $460 | 0.1% | $29.01 | -63.5% | COM | 670703107 |
| — | NUVATION BIO INC | 66,666 | $19 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |